Validity of two weight prediction models for community-living patients participating in a weight loss program.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 07 2023
Historique:
received: 05 12 2022
accepted: 12 07 2023
medline: 21 7 2023
pubmed: 20 7 2023
entrez: 19 7 2023
Statut: epublish

Résumé

Models predicting individual body weights over time clarify patient expectations in weight loss programs. The accuracy of two commonly used weight prediction models in community living people is unclear. All eligible people entering a weight management program between 1992 and 2015 were included. Patients' diet was 1200 kcal/day for week 0 followed by 900 kcal/day for weeks 1-7 and were excluded from the analysis if they were nonadherent. We generated expected weights using the National Institutes of Health Body Weight Planner (NIH-BWP) and the Pennington Biomedical Research Center Weight Loss Predictor (PBRC-WLP). 3703 adherent people were included (mean age 46 years, 72.6% women, mean [SD] weight 262.3 pounds [54.2], mean [SD] BMI 42.4 [7.6]). Mean (SD) relative body weight differences (100*[observed-expected]/expected) for NIH-BWP and PBRC-WLP models was - 1.5% (3.8) and - 2.9% (3.2), respectively. At week 7, mean squared error with NIH-BWP (98.8, 83%CI 89.7-108.8) was significantly lower than that with PBRC-WLP (117.7, 83%CI 112.4-123.4). Notable variation in relative weight difference were seen (for NIH-BWP, 5th-95th percentile was - 6.2%, + 3.7%; Δ 9.9%). During the first 7 weeks of a weight loss program, both weight prediction models returned expected weights that were very close to observed values with the NIH-BWP being more accurate. However, notable variability between expected and observed weights in individual patients were seen. Clinicians can monitor patients in weight loss programs by comparing their progress with these data.

Identifiants

pubmed: 37468655
doi: 10.1038/s41598-023-38683-9
pii: 10.1038/s41598-023-38683-9
pmc: PMC10356859
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11629

Informations de copyright

© 2023. The Author(s).

Références

Obes Res. 2002 Jul;10(7):651-6
pubmed: 12105287
J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1097-104
pubmed: 26187233
Am J Clin Nutr. 2014 Sep;100(3):806-12
pubmed: 25057153
Diabetes. 2008 Mar;57(3):548-54
pubmed: 18003759
J Vasc Surg. 2002 Jul;36(1):194-5
pubmed: 12096281
J Biol Dyn. 2011 Nov;5(6):579-599
pubmed: 24707319
Math Biosci Eng. 2009 Oct;6(4):873-87
pubmed: 19835433
Obesity (Silver Spring). 2014 Sep;22(9):1939-41
pubmed: 24895253
Curr Obes Rep. 2019 Sep;8(3):262-283
pubmed: 31214942
Metabolism. 2020 Dec;113:154388
pubmed: 33035570
Lancet. 2011 Aug 27;378(9793):826-37
pubmed: 21872751
Am J Clin Nutr. 1995 Mar;61(3):486-94
pubmed: 7872211
Am J Clin Nutr. 2018 Apr 1;107(4):558-565
pubmed: 29635495
JAMA. 2006 Apr 5;295(13):1539-48
pubmed: 16595757

Auteurs

Robert Dent (R)

Department of Medicine, The Ottawa Hospital, Ottawa, Canada.

Neil Harris (N)

Weight Management Clinic, The Ottawa Hospital, Ottawa, Canada.

Carl van Walraven (C)

Ottawa Hospital Research Institute, Institute for Clinical Evaluative Sciences, University of Ottawa, ASB1-003 1053, Carling Ave, Ottawa, ON, K1Y 4E9, Canada. carlv@ohri.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH